VANDETANIB for Neoplasm: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where VANDETANIB was used for Neoplasm.
Most Reported Side Effects for VANDETANIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 216 | 18.6% | 16 | 61 |
| Fatigue | 109 | 9.4% | 6 | 24 |
| Rash | 101 | 8.7% | 6 | 30 |
| Electrocardiogram qt prolonged | 89 | 7.7% | 4 | 51 |
| Hypertension | 88 | 7.6% | 4 | 48 |
| Disease progression | 62 | 5.4% | 4 | 24 |
| Acne | 60 | 5.2% | 3 | 17 |
| Nausea | 58 | 5.0% | 5 | 23 |
| Asthenia | 52 | 4.5% | 6 | 12 |
| Headache | 48 | 4.1% | 0 | 6 |
| Insomnia | 47 | 4.1% | 2 | 8 |
| Malignant neoplasm progression | 47 | 4.1% | 5 | 29 |
| Off label use | 46 | 4.0% | 4 | 20 |
| Pain | 43 | 3.7% | 1 | 12 |
| Death | 42 | 3.6% | 42 | 17 |
Other Indications for VANDETANIB
Thyroid cancer (591)
Medullary thyroid cancer (221)
Brain stem glioma (33)
Product used for unknown indication (28)
Paraganglion neoplasm malignant (24)
Glioblastoma (21)
Thyroid cancer metastatic (20)
Phaeochromocytoma (13)
Pancreatic carcinoma (10)
Gastrooesophageal cancer (9)
Other Drugs Used for Neoplasm
BEVACIZUMAB (502)
ATEZOLIZUMAB (404)
CYCLOPHOSPHAMIDE (385)
CARBOPLATIN (283)
PACLITAXEL (267)
NIVOLUMAB (219)
OXALIPLATIN (185)
PEMBROLIZUMAB (173)
LENALIDOMIDE (171)
DOXORUBICIN (150)